within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H02C_AntiadrenalPreparations.H02CA02_Osilodrostat;

model Osilodrostat
  extends Pharmacolibrary.Drugs.ATC.H.H02CA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>H02CA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Osilodrostat is an orally active, reversible inhibitor of the enzyme 11β-hydroxylase (CYP11B1), which is responsible for cortisol synthesis in the adrenal cortex. It is approved for the treatment of Cushing's syndrome, specifically for adults with endogenous Cushing's disease for whom pituitary surgery is not an option or has not been curative.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers, after single oral administration.</p><h4>References</h4><ol><li><p>Rasool, S, &amp; Skinner, BW (2021). Osilodrostat for the treatment of Cushing&#x27;s disease. <i>Expert opinion on pharmacotherapy</i> 22(9) 1099–1106. DOI:<a href=\"https://doi.org/10.1080/14656566.2021.1897106\">10.1080/14656566.2021.1897106</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33703978/\">https://pubmed.ncbi.nlm.nih.gov/33703978</a></p></li><li><p>Yin, L, et al., &amp; Hu, Q (2022). Design, Synthesis, and Biological Evaluations of Pyridyl 4,5,6,7-Tetrahydro-4,7-Methanobenzo[. <i>Journal of medicinal chemistry</i> 65(17) 11876–11888. DOI:<a href=\"https://doi.org/10.1021/acs.jmedchem.2c01037\">10.1021/acs.jmedchem.2c01037</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35975976/\">https://pubmed.ncbi.nlm.nih.gov/35975976</a></p></li><li><p>Papillon, JP, et al., &amp; Ksander, GM (2015). Structure-Activity Relationships, Pharmacokinetics, and in Vivo Activity of CYP11B2 and CYP11B1 Inhibitors. <i>Journal of medicinal chemistry</i> 58(11) 4749–4770. DOI:<a href=\"https://doi.org/10.1021/acs.jmedchem.5b00407\">10.1021/acs.jmedchem.5b00407</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25953419/\">https://pubmed.ncbi.nlm.nih.gov/25953419</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Osilodrostat;
